Prostatype Genomics: When lives matter - Redeye

Redeye initiates coverage of Prostatype Genomics, a company offering a prognostics test that supports the critical decision by prostate cancer (PCa) patients and specialists as to treatment type, avoiding the pain of over-treatment.

Länk till analysen i sin helhet: https://www.redeye.se/research/838406/prostatype-genomics-when-lives-matter?utm_source=finwire&utm_medium=RSS